Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells

Clinical Immunology

Volumn 92, Issue 2, 1999, Pages 161-169

  Nagaraju, Kanneboyina ^a   Raben, Nina ^a   Villalba, Maria L ^a   Danning, Carol ^a   Loeffler, Lisa A ^a   Lee, Eunice ^a   Tresser, Nancy ^a   Abati, Andrea ^a   Fetsch, Patricia ^a   Plotz, Paul H ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

CD154; CD28; CD40; CD86; Costimulatory molecules; CTLA4; Human skeletal muscle cells; Myositis

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 1;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; DERMATOMYOSITIS; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 0032814894     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4743     Document Type: Article

References (52)

1. Janeway C. A. Jr., Bottomly K. Signals and signs for lymphocyte responses. Cell. 76:1994;275.
2. Thompson, C. B, and, Allison, J. P, The emerging role of CTLA-4 as an immune attenuator, Immunity, 7, 445, 1997.
3. Durie F. H., Foy T. M., Masters S. R., Laman J. D., Noelle R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15:1994;406.
4. Ranheim E. A., Kipps T. J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:1993;925.
5. Hancock W. W., Sayegh M. H., Zheng X. G., Peach R., Linsley P. S., Turka L. A. Co-stimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA. 93:1996;13967.
6. Mohan C., Shi Y., Laman J. D., Datta S. K. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1995;1470.
7. Reiser H., Stadecker M. J. Co-stimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335:1996;1369.
8. Miller F. W., Twitty S. A., Biswas T., Plotz P. H. Origin and regulation of a disease-specific autoantibody response: Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies. J. Clin. Invest. 85:1990;468.
9. Miller F. W., Waite K. A., Biswas T., Plotz P. H. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc. Natl. Acad. Sci. USA. 87:1990;9933.
10. Targoff I. N. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J. Immunol. 144:1990;1737.
11. Targoff I. N., Trieu E. P., Miller F. W. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J. Clin. Invest. 91:1993;2556.
12. Hohlfeld R., Engel A. G. The immunobiology of muscle. Immunol. Today. 15:1994;269.
13. Adams E. M., Kirkley J., Eidelman G., Dohlman J., Plotz P. H. The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases. Proc. Assoc. Am. Physicians. 109:1997;275.
14. Lundberg I., Brengman J. M., Engel A. G. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J. Neuroimmunol. 63:1995.
15. Nagaraju K., Raben N., Merritt G., Loeffler L., Kirk K., Plotz P. H. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin. Exp. Immunol. 113:1998;407.
16. Danning C., Lee E., Illei G., Boumpas D., McInnes I. B. Cytokine and cell activation molecule expression in psoriatic arthritis synovial membrane. Clin. Exp. Rheumatol. 16:1998;111.
17. Fraser D. D., Frank J. A., Dalakas M. C. Inflammatory myopathies: MR imaging and spectroscopy. Radiology. 179:1991;341.
18. Adams E. M., Chow C. K., Premkumar A., Plotz P. H. The idiopathic inflammatory myopathies: Spectrum of MR imaging findings. Radiographics. 15:1995;563.
19. Bartlett M. L., Ginn L., Beitz L., Villalba M. L., Plotz P., Bacharach S. L. Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging. Magn. Reson. Imaging. 17:1999;183.
20. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P. MHC class I. MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95:1994;166.
21. Dariavach P., Mattei M. G., Golstein P., Lefranc M. P. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 18:1988;1901.
22. Lee K. P., Taylor C., Petryniak B., Turka L. A., June C. H., Thompson C. B. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:1990;344.
23. Andreetta F., Bernasconi P., Torchiana E., Baggi F., Cornelio F., Mantegazza R. T-cell infiltration in polymyositis is characterized by coexpression of cytotoxic and T-cell-activating cytokine transcripts. Ann. N. Y. Acad. Sci. 756:1995;418.
24. Engel, A. G, Hohlfeld, R, and, Banker, B. Q, The polymyositis and dermatomyositis syndromes, In, Myology, 2nd ed. (, A. G. Engel and C. Franzini-Armstrong, Eds.), p, 1355, McGraw-Hill, New York.
25. Engel A. G., Arahata K., Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68:1990;141.
26. Emslie-Smith A. M., Arahata K., Engel A. G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20:1989;224.
27. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann. Neurol. 23:1988;64.
28. Sayegh M. H., Turka L. A. The role of T-cell co-stimulatory activation pathways in transplant rejection. N. Engl. J. Med. 338:1998;1813.
29. Linsley P. S., Greene J. L., Brady W., Bajorath J., Ledbetter J. A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:1994;793.
30. Bluestone J. A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:1995;555.
31. Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J., Nadler L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood. 84:1994;3261.
32. Boise L. H., Noel P. J., Thompson C. B. CD28 and apoptosis. Curr. Opin. Immunol. 7:1995;620.
33. Lucas P. J., Negishi I., Nakayama K., Fields L. E., Loh D. Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:1995;5757.
34. Brunet J. F., Denizot F., Luciani M. F., Roux-Dosseto M., Suzan M., Mattei M. G., Golstein P. A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328:1987;267.
35. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721.
36. Walunas T. L., Lenschow D. J., Bakker C. Y., Linsley P. S., Freeman G. J., Green J. M., Thompson C. B., Bluestone J. A. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405.
37. Summers K. L., O'Donnell J. L., Williams L. A., Hart D. N. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis Rheum. 39:1996;1287.
38. Noelle R. J., Ledbetter J. A., Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today. 13:1992;431.
39. Grewal I. S., Flavell R. A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:1998;111.
40. Bernasconi P., Confalonieri P., Andreetta F., Baggi F., Cornelio F., Mantegazza R. The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy. J. Neuroimmunol. 85:1998;52.
41. Tivol E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone J. A., Sharpe A. H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541.
42. Tivol E. A., Boyd S. D., McKeon S., Borriello F., Nickerson P., Strom T. B., Sharpe A. H. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158:1997;5091.
43. Waterhouse P., Penninger J. M., Timms E., Wakeham A., Shahinian A., Lee K. P., Thompson C. B., Griesser H., Mak T. W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985.
44. Blair P. J., Riley J. L., Levine B. L., Lee K. P., Craighead N., Francomano T., Perfetto S. J., Gray G. S., Carreno B. M., June C. H. CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X-L induction. J. Immunol. 160:1998;12.
45. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T-cell survival by enhancing the expression of BcL-X(L). Immunity. 3:1995;87.
46. Hollsberg P., Scholz C., Anderson D. E., Greenfield E. A., Kuchroo V. K., Freeman G. J., Hafler D. A. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J. Immunol. 159:1997;4799.
47. Lindberg C., Oldfors A., Tarkowski A. Local T-cell proliferation and differentiation in inflammatory myopathies. Scand. J. Immunol. 41:1995;421.
48. Perrin P. J., Scott D., June C. H., Racke M. K. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis. Immunol. Res. 14:1995;189.
49. Nakajima A., Azuma M., Kodera S., Nuriya S., Terashi A., Abe M., Hirose S., Shirai T., Yagita H., Okumura K. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:1995;3060.
50. Finck B. K., Linsley P. S., Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 265:1994;1225.
51. Gerritse K., Laman J. D., Noelle R. J., Aruffo A., Ledbetter J. A., Boersma W. J., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 93:1996;2499.
52. Griggs N. D., Agersborg S. S., Noelle R. J., Ledbetter J. A., Linsley P. S., Tung K. S. The relative contribution of the CD28 and gp39 co-stimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:1996;801.